Intermolecular

Merck KGaA completed its acquisition of Intermolecular, Inc., a California-based advanced materials innovation company, for $1.20 per share in an all-cash transaction representing an equity value of approximately $62 million. Approximately 90 employees at Intermolecular's R&D site in San Jose, California will join Merck KGaA's Performance Materials business.